Saturday 17 October 2026 Export HBIO’s income statement to Excel — free account

Harvard Bioscience, Inc.

HBIO Healthcare Medical Instruments & Supplies

Harvard Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $86.6 million, down 8.06% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS fell 28.0%, free cash flow fell 123.4% and total debt rose 5.21%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

8.09 0.22 −2.65%

Follow HBIO

Alert me

Market cap: $37.8M
P/E: 0.0×
Fwd P/E: −3.2×
Dividend yield: —
F-score: 4/9
Altman Z: −4.01
Beneish M: −6.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(135.62%)	(147.13%)	(78.65%)	(89.95%)
Piotroski F-Score Full definition →		4	4	6	6
ROA Full definition →		(51.46%)	(54.86%)	(12.41%)	(13.32%)
ROIC Full definition →		(76.24%)	(74.07%)	(0.14%)	(0.41%)
Return on Tangible Assets Full definition →		961.17%	(182.60%)	(34.35%)	(38.54%)
Average Days of Receivables Full definition →		50.59	67.66	62.19	60.27
Free Cash Flow per Share Full definition →		1.53	1.10	0.29	(0.40)
Free Cash Flow Full definition →		6.82	4.87	1.28	(1.83)
Capital Expenditures Full definition →		(1.73)	(1.86)	(1.80)	(2.48)
Other line items
Cash ROIC Full definition →		12.43%	8.36%	2.40%	(3.62%)
Accounts Receivable Turnover Full definition →		7.01	5.60	6.10	6.64
Accounts Payable Turnover Full definition →		7.19	8.68	7.05	6.71
Inventory Turnover Full definition →		1.58	1.66	1.58	1.65
Average Days of Payables Full definition →		50.22	36.38	54.27	61.83
Days of Inventory on Hand Full definition →		209.60	207.26	227.91	220.84
Tax Rate Full definition →		0.00	(0.01)	(0.01)	(0.01)
Research and Development Expense of Revenue Full definition →		10.27%	10.20%	10.32%	10.36%
Selling, General and Administrative Expense of Revenue Full definition →		43.43%	42.70%	43.07%	43.34%
Share Based Compensation of Revenue Full definition →		2.70%	2.14%	1.77%	1.62%
Interest Coverage Full definition →		(12.32)	(9.88)	(0.02)	(0.04)
Operating CF/Net income Full definition →		(0.16)	(0.12)	(0.31)	(0.06)
Depreciation/Fixed assets Full definition →		11.04	11.54	1.49	1.37
Capex/Depreciation Full definition →		(0.03)	(0.03)	(0.25)	(0.34)
Revenue per Share Full definition →		19.61	19.50	19.12	19.40
Operating CF per Share Full definition →		1.92	1.52	0.69	0.14
Capex per Share Full definition →		(0.39)	(0.42)	(0.40)	(0.55)
Capex to Sales Full definition →		0.02	0.02	0.02	0.03

Show all line items

Columns are period end dates

Stockrow Weekly